Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 6888

1.

Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment.

Greenlee H, DuPont-Reyes MJ, Balneaves LG, Carlson LE, Cohen MR, Deng G, Johnson JA, Mumber M, Seely D, Zick SM, Boyce LM, Tripathy D.

CA Cancer J Clin. 2017 Apr 24. doi: 10.3322/caac.21397. [Epub ahead of print] Review.

2.

Managing the patient with osteogenesis imperfecta: a multidisciplinary approach.

Marr C, Seasman A, Bishop N.

J Multidiscip Healthc. 2017 Apr 4;10:145-155. doi: 10.2147/JMDH.S113483. eCollection 2017. Review.

3.

Development of School-Based Asthma Management Programs in Rochester, NY.

Halterman JS, Tajon R, Tremblay P, Fagnano M, Butz A, Perry T, McConnochie K.

Acad Pediatr. 2017 Apr 18. pii: S1876-2859(17)30164-X. doi: 10.1016/j.acap.2017.04.008. [Epub ahead of print] Review.

PMID:
28434913
4.

Apolipoprotein E, Receptors, and Modulation of Alzheimer's Disease.

Zhao N, Liu CC, Qiao W, Bu G.

Biol Psychiatry. 2017 Mar 14. pii: S0006-3223(17)31358-6. doi: 10.1016/j.biopsych.2017.03.003. [Epub ahead of print] Review.

PMID:
28434655
5.

Lipids as central modulators of sensory TRP channels.

Ciardo MG, Ferrer-Montiel A.

Biochim Biophys Acta. 2017 Apr 18. pii: S0005-2736(17)30128-1. doi: 10.1016/j.bbamem.2017.04.012. [Epub ahead of print] Review.

PMID:
28432033
6.

Cognitive-behavioral high parental involvement treatments for pediatric obsessive-compulsive disorder: A meta-analysis.

Iniesta-Sepúlveda M, Rosa-Alcázar AI, Sánchez-Meca J, Parada-Navas JL, Rosa-Alcázar Á.

J Anxiety Disord. 2017 Apr 4;49:53-64. doi: 10.1016/j.janxdis.2017.03.010. [Epub ahead of print] Review.

PMID:
28431305
7.

Poly(adenosine diphosphate-ribose) polymerase as therapeutic target: lessons learned from its inhibitors.

Cseh AM, Fábián Z, Sümegi B, Scorrano L.

Oncotarget. 2017 Apr 5. doi: 10.18632/oncotarget.16859. [Epub ahead of print] Review.

8.

Potential application and prevalence of the CD30 (Ki-1) antigen among solid tumors: A focus review of the literature.

Berger GK, Gee K, Votruba C, McBride A, Anwer F.

Crit Rev Oncol Hematol. 2017 May;113:8-17. doi: 10.1016/j.critrevonc.2017.02.021. Epub 2017 Feb 27. Review.

PMID:
28427526
9.

FGFR a promising druggable target in cancer: Molecular biology and new drugs.

Porta R, Borea R, Coelho A, Khan S, Araújo A, Reclusa P, Franchina T, Van Der Steen N, Van Dam P, Ferri J, Sirera R, Naing A, Hong D, Rolfo C.

Crit Rev Oncol Hematol. 2017 May;113:256-267. doi: 10.1016/j.critrevonc.2017.02.018. Epub 2017 Mar 23. Review.

PMID:
28427515
10.

Trichorhinophalangeal Syndrome.

Maas S, Shaw A, Bikker H, Hennekam RCM.

In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017.
2017 Apr 20.

11.

Inherited Variation in Vitamin D Genes and Type 1 Diabetes Predisposition.

Penna-Martinez M, Badenhoop K.

Genes (Basel). 2017 Apr 20;8(4). pii: E125. doi: 10.3390/genes8040125. Review.

12.

Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs).

Rathore R, McCallum JE, Varghese E, Florea AM, Büsselberg D.

Apoptosis. 2017 Apr 19. doi: 10.1007/s10495-017-1375-1. [Epub ahead of print] Review.

PMID:
28424988
13.

Recent Advances: The Imbalance of Cytokines in the Pathogenesis of Inflammatory Bowel Disease.

Guan Q, Zhang J.

Mediators Inflamm. 2017;2017:4810258. doi: 10.1155/2017/4810258. Epub 2017 Mar 21. Review.

14.

Simulated presence therapy for dementia.

Abraha I, Rimland JM, Lozano-Montoya I, Dell'Aquila G, Vélez-Díaz-Pallarés M, Trotta FM, Cruz-Jentoft AJ, Cherubini A.

Cochrane Database Syst Rev. 2017 Apr 18;4:CD011882. doi: 10.1002/14651858.CD011882.pub2. [Epub ahead of print] Review.

PMID:
28418586
15.

ErbB Family Signalling: A Paradigm for Oncogene Addiction and Personalized Oncology.

Jacobi N, Seeboeck R, Hofmann E, Eger A.

Cancers (Basel). 2017 Apr 12;9(4). pii: E33. doi: 10.3390/cancers9040033. Review.

16.

Updates in Decompression Illness.

Pollock NW, Buteau D.

Emerg Med Clin North Am. 2017 May;35(2):301-319. doi: 10.1016/j.emc.2016.12.002. Epub 2017 Mar 15. Review.

PMID:
28411929
17.

Development, prevention, and treatment of feeding tube dependency.

Krom H, de Winter JP, Kindermann A.

Eur J Pediatr. 2017 Apr 13. doi: 10.1007/s00431-017-2908-x. [Epub ahead of print] Review.

PMID:
28409284
18.

Targeting ROR1 identifies new treatment strategies in hematological cancers.

Karvonen H, Niininen W, Murumägi A, Ungureanu D.

Biochem Soc Trans. 2017 Apr 15;45(2):457-464. doi: 10.1042/BST20160272. Review.

PMID:
28408486
19.

EMP1, EMP 2, and EMP3 as novel therapeutic targets in human cancer.

Wang YW, Cheng HL, Ding YR, Chou LH, Chow NH.

Biochim Biophys Acta. 2017 Apr 10;1868(1):199-211. doi: 10.1016/j.bbcan.2017.04.004. [Epub ahead of print] Review.

PMID:
28408326
20.

X-Linked Hypophosphatemia.

Ruppe MD.

In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017.
2012 Feb 9 [updated 2017 Apr 13].

Supplemental Content

Loading ...
Support Center